Skip NavigationSkip to Content

Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones

  1. Author:
    Bortolozzi, Roberta
    Carta, Davide
    Prà, Matteo Dal
    Antoniazzi, Giuseppe
    Mattiuzzo, Elena
    Sturlese, Mattia
    Di Paolo, Veronica
    Calderan, Laura
    Moro, Stefano
    Hamel,Ernest
    Quintieri, Luigi
    Ronca, Roberto
    Viola, Giampietro
    Ferlin, Maria Grazia
  2. Author Address

    Department of Woman's and Child's Health, University of Padova, Laboratory of Oncohematology, 35128, Padova, Italy., Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131, Padova, Italy., Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA., Department of Molecular and Translational Medicine, Oncology and Immunology Section, University of Brescia, 29881, Brescia, Italy., Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131, Padova, Italy. Electronic address: mariagrazia.ferlin@unipd.it.,
    1. Year: 2019
    2. Date: Sep 15
    3. Epub Date: 2019 06 03
  1. Journal: European journal of medicinal chemistry
    1. 178
    2. Pages: 297-314
  2. Type of Article: Article
  3. ISSN: 0223-5234
  1. Abstract:

    A small number of fluorinated 7-phenyl-pyrroloquinolinone (7-PPyQ) derivatives was synthesized in an attempt to improve the metabolic stability of 3N-ethyl-7-PPyQ and 3N-benzoyl-7-PPyQ. The possible impacts of the fluorine-hydrogen isosterism on both biological activity and metabolic stability were evaluated. Introduction of a fluorine atom in the 2 or 3 position of the 7-phenyl ring yielded the 7-PPyQ derivatives 12, 13 and 15, which showed potent cytotoxicity (low micromolar and sub-nanomolar GI50s) both in human leukemic and solid tumor cell lines. None of them induced significant cell death in quiescent and proliferating human lymphocytes. Moreover, 12, 13 and 15 exhibited remarkable cytotoxic activity in the multidrug-resistant cell line CEMVbl100, suggesting that they are not substrates for P-glycoprotein. All compounds inhibited tubulin assembly and the binding of [3H]colchicine to tubulin, with the best activity occurring with compound 15. Mechanistic studies carried out on compound 12 indicated that it caused (a) a strong G2/M arrest; (b) apoptosis in a time- and concentration-dependent manner; (c) a significant production of ROS (in good agreement with the observed mitochondrial depolarization); (d) caspase-3 and poly (ADP-ribose) polymerase activation; and (e) a decrease in the expression of anti-apoptotic proteins. In vivo experiments in a murine syngeneic tumor model demonstrated that compounds 12 and 15 significantly reduced tumor mass at doses four times lower than that required for the reference compound combretastatin A-4 phosphate. Neither monofluorination of the 7-phenyl ring of 3N-ethyl-7-PPyQ nor replacement of the benzoyl function of 3N-benzoyl-7-PPyQ with a 2-fluorobenzoyl moiety led to any improvement in the metabolic stability. Copyright © 2019 Elsevier Masson SAS. All rights reserved.

    See More

External Sources

  1. DOI: 10.1016/j.ejmech.2019.05.092
  2. PMID: 31195171
  3. WOS: 000480664100022
  4. PII : S0223-5234(19)30516-1

Library Notes

  1. Fiscal Year: FY2018-2019
NCI at FrederickClose Button

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel